Market revenue in 2023 | USD 77.5 million |
Market revenue in 2030 | USD 150.9 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.06% in 2023. Horizon Databook has segmented the Canada deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
In Canada, deep brain stimulation devices market is mainly driven by rising incidence of mental disorders. Moreover, approximately 2% of the population has obsessive compulsive disorder, according to Canadian Psychological Association. In addition, frequent approvals of deep brain stimulation devices by Health Canada are anticipated to promote the market growth in this country.
For instance, in June 2017, Medtronic received Health Canada license for its SureTune3 software for deep brain stimulation devices. Increasing preference for epilepsy specialists for deep brain stimulation devices therapy and rising number of epilepsy specialty centers are also key factors boosting demand for deep brain stimulation devices.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account